The role of TGF-β1 C-509T and TGF-β1 T869C polymorphisms in susceptibility to tuberculosis infection in a Sudanese population: a case-control study Authors: Salma A. Moharrum, Naser Eldin Bilal, Najwa A. Mhmoud Published: 2025 ABSTRACT BackgroundTuberculosis (TB) affects around 10 million people globally every year. The death rate from TB disease is substantial (almost 50%) if treatment is not received. In 2023, Sudan’s tuberculosis incidence is estimated at 134 cases per 100,000 population, with a 95% confidence interval of 125 to 145 cases per 100,000. The current tuberculosis mortality rate in Sudan is estimated at 25.0 deaths per 100,000 individuals. Several previous studies established an association between different cytokine genetic variants and TB across different ethnic groups. To our knowledge, no published studies have investigated the association between TGFβ1 polymorphisms (such as −509 C/T or T869C) and tuberculosis susceptibility in the Sudanese population.MethodA case-control study was conducted at Abu Anja Chest Hospital, Omdurman, Khartoum State, Sudan, between February 2018 and February 2021. A total of 200 EDTA blood samples were collected from patients newly diagnosed with pulmonary tuberculosis, and 200 EDTA blood samples from healthy controls. DNA extraction was done using the guanidine chloride method. Genotyping was performed using PCR-RFLP to investigate the influence of the TGF-β1 C-509T and TGF-β1 T869C polymorphisms on the susceptibility of Sudanese patients to pulmonary tuberculosis infection. Version 20.0 of IBM SPSS was used to analyze the data. (IBM Corp., Armonk, NY).ResultThe mutant and heterozygous genotypes in the TGF-β1-509 C/T polymorphism were associated with a nearly threefold increased risk of TB development in the Sudanese population (P-value < 0.001, OR 2.688, 95% CI 1.638–4.411). No statistically significant differences in genotype or allele frequencies of the TGF-β1 T869C gene were observed between patients and controls.ConclusionThe presence of even a single mutant allele (C) in this locus, 509T in TGFβ1, confers a significant risk of developing TB in Sudanese ethnics.Clinical trial numberNot applicable. This article is extracted from my Ph.D. thesis entitled: The Role of Host Cytokine Genetic Polymorphism in Susceptibility to Mycobacterium Tuberculosis Infection.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12879-025-12256-9. Background Tuberculosis (TB) is caused by the bacterium, Mycobacterium tuberculosis, which is released into the air through coughing or other respiratory exhalations by individuals with active TB. Approximately 10 million new TB cases are reported worldwide each year [1, 2]. It is believed that around 25% of the global population has contracted tuberculosis [3]. In 2023, Sudan’s tuberculosis incidence is estimated at 134 cases per 100,000 population, with a 95% confidence interval ranging from 125 to 145 cases per 100,000. The current tuberculosis mortality rate in Sudan is estimated at 25.0 deaths per 100,000 individuals [4]. The risk of developing active tuberculosis is highest within the first two years after initial infection, estimated at approximately 5%, and declines substantially thereafter [5]. Pulmonary tuberculosis typically affects the lungs, but it can also spread to other parts of the body [4]. The death rate from TB disease is substantial (almost 50%) if treatment is not received [6]. A Sudanese meta-analysis examined 16 studies to estimate the prevalence of pulmonary tuberculosis. The pooled prevalence was 30.72% (95% CI: 30.64–30.81). With 2,737 people, Khartoum State had the highest pooled prevalence at 41.86% (CI: 14.69, 69.02) [7]. During Sudan’s armed war, the incidence rate of tuberculosis increased significantly, rising from 54 per 100,000 to 63 per 100,000. Multidrug resistance, noncompliance with treatment protocols, and recurring disease all increased during the war. Men, workers, and those involved in gold mining are the groups most impacted. The pleura, lymph nodes, and abdominal regions are increasingly showing signs of extrapulmonary tuberculosis [8]. With an estimated heritability ranging from 36% to 80%, heritability studies have demonstrated that a person’s genetic background influences their immune response to tuberculosis infection. Insufficient data suggest that host genetic traits play a role in certain individuals’ superior resistance to infection [9, 10]. Cytokine gene polymorphisms have long been recognized as influencing cytokine levels, which, in turn, may affect a person’s susceptibility to TB infection and disease. Variations in cytokine expression probably determine whether tuberculosis progresses, goes away, or remains latent [11]. Several previous studies established an association between different cytokine genetic variants and TB across different ethnic groups, including [12]. Understanding the host genetic factors that control tuberculosis susceptibility is expected to lead to a new and more effective way to prevent and cure this debilitating disease. Many of the genes and mechanisms that determine an individual’s susceptibility to tuberculosis remain unclear, despite some advancements in this field. The versatile cytokine known as transforming growth factor-β1 (TGF-β1) plays a crucial role in promoting local angiogenesis, extracellular matrix secretion, immunological evasion, cell heterogeneity and adhesion, cell proliferation, invasion, metastasis, and other processes [13]. The TGF-β1 gene is located on the long arm of chromosome 19 and consists of six introns and seven exons. Among these, the first exon has a higher rate of gene mutations and single-nucleotide polymorphisms (SNPs), which are strongly associated with the formation of a range of malignant tumors, including those of the esophagus, breast, prostate, liver, and other cancers [14, 15]. Additionally, it has been reported to suppress T-cell responses and inactivate macrophages in patients with tuberculosis [16, 17]. A tuberculosis granuloma model showed that the knockout of TGF-β1 benefits bacterial clearance by cytotoxic T cells [18]. Both TGF-β1 C-509T and TGF-β1 T869C polymorphisms (SNPs) are located in regulatory or coding regions, which may directly affect TGF-β1 expression or protein functions. TGF-β1 C-509T is located in the promoter region, where it can modify transcriptional activity [19], while T869C is a unique polymorphism in exon 1, leading to an amino acid substitution (Leu10Pro), which affects protein secretion. Previous research has highlighted their functional impact on cytokine concentrations and immune responses [20]. These SNPs have been frequently investigated in diverse populations and have shown reproducible associations with susceptibility to various infectious and inflammatory diseases, including tuberculosis [21–24]. However, to date, there have been extremely limited studies investigating the association between the TGF-β1 gene polymorphisms and susceptibility to human tuberculosis. Mak JCW et al. conducted one of the first investigations in this area to examine the association between TGF-β1 gene polymorphisms (C-509T and T869C) and plasma levels with the risk of tuberculosis in Chinese adults from Hong Kong. Based on their results, they concluded that TGF-β1 gene polymorphisms at C-509T and T869C were not associated with TB susceptibility in Hong Kong Chinese adults, but the elevated plasma TGF-β1 levels suggest that this cytokine may play a role in the pathogenesis of tuberculosis [21]. Zhang S. et al. investigated the relationship between single-nucleotide polymorphisms (SNPs) in the TGF-β1 gene and increased susceptibility to tuberculosis using a discovery cohort. They employed Zhang G. et al. [25] technique to identify 10 possibly functional SNPs in the TGF-β1 gene. Five of the ten SNPs in the discovery cohort are highly linked to TB susceptibility, including two in the TGF-β1 intron, located in the 5’ untranslated region (UTR) (rs4803455 and rs11466334) and three in the TGF-β1 promoter region (rs2317130, rs4803457, and rs11466313). There is no correlation between the remaining five SNPs (rs17516265, positioned in the intronic region; rs3087453, positioned in the intronic region; TGF-β1 C-509T, promoter region polymorphism; rs2278422, positioned in the intronic region; and rs8110090, positioned in the intronic region) and the risk of developing tuberculosis. An increased risk of TB susceptibility is shown by the rs2317130 C allele [25]. To the best of our knowledge, no published studies have investigated the association between TGF-β1 polymorphisms (− 509 C/T or T869C) and tuberculosis susceptibility in the Sudanese population. Moreover, given the practical limitations of sample size, resources, and the study’s scope, we prioritized single-nucleotide polymorphisms (SNPs) with the most compelling evidence of functional significance and extensive clinical relevance, rather than investigating the genotypes of the five SNPs referenced by Zhang S. et al. Consequently, although Zhang S. et al. identified five single-nucleotide polymorphisms linked to tuberculosis risk in their discovery cohort, we intentionally concentrated on C-509T and T869C because of their demonstrated biological plausibility, functional significance, and prior validation across diverse ethnic groups. Therefore, this study examines the potential association between polymorphisms in the TGF-β1 C-509T and TGF-β1 T869C genes and susceptibility to pulmonary tuberculosis (PTB). Methods Study population A prospective, cross-sectional, case-control study was conducted between February 2018 and February 2021 at Abu Anjaa Chest Hospital in Omdurman, Khartoum State, Sudan. The study involved Sudanese patients with proven active pulmonary tuberculosis who agreed to participate irrespective of age or gender. Patients with other immune-related disorders, such as HIV, diabetes, cancer, and autoimmune diseases, were excluded from the study. A total of 200 EDTA blood specimens were obtained from patients with proven pulmonary tuberculosis. All the active PTB participants were treatment-naïve at the time of recruitment. In addition, 200 EDTA blood specimens were obtained from healthy individuals as a control group. The sample size for this study was calculated using a standard statistical formula based on the prevalence of Mycobacterium tuberculosis infection in Sudan. Specifically, we applied the equation:[26] \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\text{N}=\text{t}^2\times\text{p}\:(1-\text{p}) \div \text{m}^2$$\end{document} Description: N = Required sample size t = Confidence level at 95% (standard value of 1.96) p = Estimated prevalence of the disease or study subject m = Margin of error at 5% (standard value of 0.05 P = 0.151% (Prevalence of MT-infected patients in Sudan) [27] \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\:N\:=\:\frac{\left(1.96\right)2\:\times\:0.151(1-0.151)}{{\left(0.05\right)}^{2}}$$\end{document} \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\text{N}=\frac{3.842 \times 0.128}{0.0025}=196.7$$\end{document} Accordingly, we rounded up to 200 participants to ensure adequate statistical power (≥ 95%). The healthy participants were recruited based on the absence of clinical symptoms of tuberculosis and a negative history of TB exposure; however, neither the Interferon-Gamma Release Assay (IGRA) nor the Tuberculin Skin Test (TST) was performed to exclude latent TB infection (LTBI) formally. The patients and controls were matched according to age and gender. Table 1 shows the demographic distribution of the study population by age group and gender. Table 1Demographic distribution of the study population by age group and genderAge group (years)Male n (%)Female n (%)Male n (%)Female n (%)Cases (n = 200)Controls (n = 200)Less than 21 years9 (4.5%)7 (3.5%)7 (3.5%)6 (3%)21–30 years59 (29.5%)22 (11%)29 (14.5%)21(10.5%)31–40 years41 (20.5%)6 (3%)32 (16%)47 (23.5%)41–50 years20 (10%)3 (1.5%)18 (9%)22 (11%)51–60 years13 (6.5%)7 (3.5%)11 (5.5%)4 (2%) More than 61 years 9 (4.5%)4 (2%)0 (0%)3 (1.5%) Total 151 (75.5%)49 (24.5%)97 (48.5%)103 (51.5%) Table 1Demographic distribution of the study population by age group and genderAge group (years)Male n (%)Female n (%)Male n (%)Female n (%)Cases (n = 200)Controls (n = 200)Less than 21 years9 (4.5%)7 (3.5%)7 (3.5%)6 (3%)21–30 years59 (29.5%)22 (11%)29 (14.5%)21(10.5%)31–40 years41 (20.5%)6 (3%)32 (16%)47 (23.5%)41–50 years20 (10%)3 (1.5%)18 (9%)22 (11%)51–60 years13 (6.5%)7 (3.5%)11 (5.5%)4 (2%) More than 61 years 9 (4.5%)4 (2%)0 (0%)3 (1.5%) Total 151 (75.5%)49 (24.5%)97 (48.5%)103 (51.5%) Demographic distribution of the study population by age group and gender Ethical consideration Ethical approval for this study was secured from the Research Ethics Committee, Faculty of Medical Laboratory Sciences, University of Khartoum (Approval No. UK-FMLS2018/0624). All study procedures adhered strictly to the ethical standards established by the committee and complied with the principles delineated in the Declaration of Helsinki. Written informed consent was obtained from each research participant before they signed the informed consent form and completed the questionnaire. A parent or other legally appointed representative provided informed consent for participants under 18, and the minor participants’ agreement was obtained in accordance with their age and comprehension level. Privacy was maintained through the use of a structured, coded questionnaire specifically designed for this study (Appendix I). Diagnosis of TB infection Mycobacterium tuberculosis was diagnosed using microbiological evidence and clinical examination. The primary diagnostic test was the Ziehl-Neelsen stain (ZN), and GeneXpert molecular diagnostics confirmed the diagnosis. The GeneXpert MTB/RIF Ultra (Xpert) assay was carried out in compliance with the manufacturer’s recommendations, as advised by the Cepheid manual [28]. DNA extraction DNA has been extracted from fresh whole blood using the guanidine chloride procedure, as described by Chen XG et al. [29]. Before storage, the DNA specimens were quantified and checked for purity with a spectrophotometer. The absorbance ratio at 260 and 280 nm (A260/A280) was applied to determine the purity and quantity of isolated DNA samples. This ratio was calculated using a Nanodrop UV-VIS spectrophotometer (EMPLEN). Then, electrophoresis of 5 µL of extracted DNA specimens was done on a 1% agarose gel to identify degradation during extraction. DNA specimens were stored at -20 °C for further investigation. Genotyping All genomic variants of the genes in this study were detected using PCR, followed by restriction enzyme fragment length polymorphism (PCR-RFLP) analysis, as previously described in [30, 31]. PCR was performed in a 10 µL reaction mixture containing genomic DNA, primers (Macrogen Europe), and a ready-to-use master mix (SOLIS BIODYNE). PCR was carried out using a thermocycler (Applied Biosystems, USA). Then, the PCR products were digested with the appropriate restriction enzymes under standard conditions and separated by 2% agarose gel electrophoresis, stained with 0.1 mg/µL ethidium bromide. The size of the DNA bands was determined by comparison with a 100 bp DNA ladder. The representative digestion patterns are shown in Figs. 1 and 2. For TGF-β1 C-509T, the cycling conditions include an initial denaturation at 93 °C for 5 min, followed by 30 cycles of denaturation at 93 °C for 45 s, annealing at 54 °C for 45 s, and extension at 72 °C for 45 s, with a final extension at 72 °C for 7 min. All amplicons had a final cooling step at 4 °C before visualization under UV light using agarose gel electrophoresis. For the TGF-β1 T869C gene, the initial denaturation was performed at 94 °C for 5 min. A total of 35 cycles consisted of 94 °C for 30 s of denaturation, 66 °C for 30 s of annealing, and 72 °C for 30 s of extension, followed by a final extension at 72 °C for 7 min. All the PCR primers, restriction enzymes, and reaction conditions are summarized in Table 2. Table 2PCR primers and restriction enzymes for genotyping all genes included in the studyGene(s)Rs numberPrimer sequence(s)(5’→-3’)REAllele PhenotypeReferenceTGF- β1 C-509T(rs 1800469)F: 5’-CAG ACT CTA GAG ACT GTC AG-3’R: 5’-GTC ACC AGA GAA AGA GGA C-3’Eco81IT: 418C: 400, 18 [30]TGF- β1 T + 869 C(rs 1800470)F: 5’-ACC ACA CCA GCC CTG TTC GC-3’R: 5’-ACC ACA CCA GCC CTG TTC GC-3’PstIC: 110T: 85, 25 [31]F: Forward, R: Reverse, RE: Restriction Enzyme Table 2PCR primers and restriction enzymes for genotyping all genes included in the studyGene(s)Rs numberPrimer sequence(s)(5’→-3’)REAllele PhenotypeReferenceTGF- β1 C-509T(rs 1800469)F: 5’-CAG ACT CTA GAG ACT GTC AG-3’R: 5’-GTC ACC AGA GAA AGA GGA C-3’Eco81IT: 418C: 400, 18 [30]TGF- β1 T + 869 C(rs 1800470)F: 5’-ACC ACA CCA GCC CTG TTC GC-3’R: 5’-ACC ACA CCA GCC CTG TTC GC-3’PstIC: 110T: 85, 25 [31]F: Forward, R: Reverse, RE: Restriction Enzyme PCR primers and restriction enzymes for genotyping all genes included in the study F: 5’-CAG ACT CTA GAG ACT GTC AG-3’ R: 5’-GTC ACC AGA GAA AGA GGA C-3’ T: 418 C: 400, 18 F: 5’-ACC ACA CCA GCC CTG TTC GC-3’ R: 5’-ACC ACA CCA GCC CTG TTC GC-3’ C: 110 T: 85, 25 F: Forward, R: Reverse, RE: Restriction Enzyme Statistical analysis The IBM SPSS software, version 20.0 (Armonk, NY: IBM Corp.), was used to analyze the data entered into the computer. Numbers and percentages were used to describe qualitative data. The significance of the findings was evaluated at the 5% level. The Chi-square test was employed to evaluate the relationships among demographic, epidemiological, genetic, and outcome characteristics (TB, study groups, and cytokine gene polymorphisms). Fisher’s Exact test was used to adjust the chi-square when more than 20% of the cells had an expected count of less than 5. Logistic regression testing was used to calculate odds ratios (OR) for the genetic factors and outcomes. The test was considered statistically significant when the P-value was less than 0.05. Using the Hardy-Weinberg Equilibrium (HWE), the allele frequencies of several gene polymorphisms were determined. Results Screening for polymorphisms in TGF-β1 C-509T The amplification of TGF- β1 C-509T gene polymorphisms of all cases and controls yielded a 418 bp fragment, which was subjected to digestion by the Eco81I restriction enzyme. The digested product showed three different patterns: wild-type homozygote (T/T), demonstrating 418 bp fragments; polymorphic homozygote (C/C) with 400 and 18 bp fragments; and C/T heterozygote with 418, 400, and 18 bp fragments. The 18 bp fragment was not shown due to its small size. The ethidium bromide-stained gel of each SNP for homozygous and heterozygous individuals is illustrated in Fig. 1. Fig. 1PCR-RFLP analysis for TGF-β1 C-509T polymorphism. The genotyping of the TGF-β1 C-509T polymorphism resulted in three patterns, with 418 bp bands representing the wild homozygous genotype (T/T), 400, 18 bp fragments representing the polymorphic homozygote (C/C), and 418, 400, and 18 bp fragments representing the heterozygote C/T genotype. Lanes 1, 6, and 7 indicate the heterozygote C/T genotype; Lanes 2, 3, and 5 indicate the wild homozygous genotype (T/T). Lane L shows the 100 bp DNA ladder. The size of each band is marked beside the gel PCR-RFLP analysis for TGF-β1 C-509T polymorphism. The genotyping of the TGF-β1 C-509T polymorphism resulted in three patterns, with 418 bp bands representing the wild homozygous genotype (T/T), 400, 18 bp fragments representing the polymorphic homozygote (C/C), and 418, 400, and 18 bp fragments representing the heterozygote C/T genotype. Lanes 1, 6, and 7 indicate the heterozygote C/T genotype; Lanes 2, 3, and 5 indicate the wild homozygous genotype (T/T). Lane L shows the 100 bp DNA ladder. The size of each band is marked beside the gel Screening for polymorphisms in TGF-β1 T869C The amplification of TGF- β1 T869C polymorphism generated a 110 bp product. The PCR product was then subjected to digestion with the PstI enzyme using the RFLP technique. All cases and controls were genotyped as T/T, with a 110 bp allele. The ethidium bromide-stained gel of each SNP for homozygous T/T individuals is illustrated in Fig. 2. Fig. 2PCR-RFLP analysis for TGF- β1 T869C polymorphism. The genotyping of the TGF- β1 T869C polymorphism generated a 110 bp product representing the wild homozygous genotype (T/T). Lanes 1, 2,3, 4, 5, 6, 7, 8, and 9 indicate the homozygous genotype (T/T). Lane L shows the 50 bp DNA ladder. The size of each band is marked beside the gel PCR-RFLP analysis for TGF- β1 T869C polymorphism. The genotyping of the TGF- β1 T869C polymorphism generated a 110 bp product representing the wild homozygous genotype (T/T). Lanes 1, 2,3, 4, 5, 6, 7, 8, and 9 indicate the homozygous genotype (T/T). Lane L shows the 50 bp DNA ladder. The size of each band is marked beside the gel The findings of the current study reported a statistically significant association between the TGF- β1 C-509T gene polymorphism and TB. Genotype distribution revealed that the mutant genotype TC was more frequent in TB cases than in controls (50.5% versus 29.0%) (P-value < 0.001), with an odds ratio (OR) of 2.498 and a 95% confidence interval of 1.654–3.773. The wild genotype TT was predominantly associated with the control group, comprising 71% of the control versus 49.5% of the cases (Table 3). Table 3Genotype distribution, allele distribution, and Hardy-Weinberg equilibrium of TGF-β1 C-509T and TGF-β1 T869C polymorphism among the cases and the control groupsGenotypesTuberculosisHWE of patientpopulationControlsHWE of ControlpopulationOR (95% CI)P-value N % N %TGF-β1 C-509TTT9949.5< 0.00114271Reference1.0< 0.001TC10150.558290.0162.498 (1.654–3.773CC0000-Allele T29974.834285.51.0< 0.001Allele C10125.25814.51.992 (1.392–2.85)TGF- β1 T869CTT200100-200100Reference--TC0000CC0000Allele T4001004001001.000-Allele C0000OR Odds Ratio Table 3Genotype distribution, allele distribution, and Hardy-Weinberg equilibrium of TGF-β1 C-509T and TGF-β1 T869C polymorphism among the cases and the control groupsGenotypesTuberculosisHWE of patientpopulationControlsHWE of ControlpopulationOR (95% CI)P-value N % N %TGF-β1 C-509TTT9949.5< 0.00114271Reference1.0< 0.001TC10150.558290.0162.498 (1.654–3.773CC0000-Allele T29974.834285.51.0< 0.001Allele C10125.25814.51.992 (1.392–2.85)TGF- β1 T869CTT200100-200100Reference--TC0000CC0000Allele T4001004001001.000-Allele C0000OR Odds Ratio Genotype distribution, allele distribution, and Hardy-Weinberg equilibrium of TGF-β1 C-509T and TGF-β1 T869C polymorphism among the cases and the control groups OR Odds Ratio The application of the Hardy-Weinberg Equilibrium (H-W) revealed a statistically significant difference between the study’s findings and the H-W expectation among both cases and controls (P-value < 0.001). The frequency of the mutant allele C was significantly higher in TB, representing 25.2% versus 14.5% in the control group (P-value < 0.001), OR = 1.992, 95% Confidence Interval = (1.392–2.85). Allele T was shown to be protective against TB (Table 3). The statistical analysis of the genotype distribution of the TGF-β1 T869C gene polymorphism revealed no variation between the TB cases and the controls. Our results revealed that all cases and controls carried the homozygous genotype TT, representing 100% of each group, respectively. The frequency of the wild-type allele T was equal in both TB cases and controls, representing 100% for each, respectively (Table 3). In the analysis of the different genetic models for TGF-β1 − 509 C/T, the dominant (TC + CC vs. TT) showed a significant association with TB, indicating that carrying at least one C allele (in a heterozygous state) increases the risk of TB (OR = 2.498, 95% CI (1.654–3.773), P-value < 0.001). The over-dominant model (TC vs. TT + CC) also showed significant susceptibility to TB, with the TC genotype conferring a higher risk (OR = 2.498, 95% CI (1.654–3.773), P-value < 0.001). On the other hand, the recessive model (CC vs. TT + TC) could not be evaluated due to the absence of the CC genotype in both groups. The absence of the CC genotype may be due to its rarity in this population or the limited sample size (Table 4). Table 4Comparison between the two studied groups according to the different genetic models for TGF-β1 C-509TTuberculosis (n = 200)Control(n = 200)OR (95% CI)P-value TGF-β1-C-509T TT99(49.5%)142(71.0%)ReferenceTC101(50.5%)58(29.0%)2.498 (1.654–3.773)< 0.001CC0(0.0%)0(0.0%)–– Allele T299(74.8%)342(85.5%)ReferenceC101(25.2%)58(14.5%)1.992 (1.392–2.85)< 0.001 Dominant TT99(49.5%)142(71.0%)ReferenceTC + CC101(50.5%)58(29%)2.498(1.654–3.773)< 0.001 Recessive TT + TC200(100.0%)200(100.0%)CC0(0.0%)0(0.0%)–– Over dominant TT + CC99(49.5%)142(71.0%)ReferenceTC101(50.5%)58(29.0%)2.498 (1.654–3.773)< 0.001OR: Odds ratio CI: Confidence interval LL: Lower limit UL: Upper Limit Table 4Comparison between the two studied groups according to the different genetic models for TGF-β1 C-509TTuberculosis (n = 200)Control(n = 200)OR (95% CI)P-value TGF-β1-C-509T TT99(49.5%)142(71.0%)ReferenceTC101(50.5%)58(29.0%)2.498 (1.654–3.773)< 0.001CC0(0.0%)0(0.0%)–– Allele T299(74.8%)342(85.5%)ReferenceC101(25.2%)58(14.5%)1.992 (1.392–2.85)< 0.001 Dominant TT99(49.5%)142(71.0%)ReferenceTC + CC101(50.5%)58(29%)2.498(1.654–3.773)< 0.001 Recessive TT + TC200(100.0%)200(100.0%)CC0(0.0%)0(0.0%)–– Over dominant TT + CC99(49.5%)142(71.0%)ReferenceTC101(50.5%)58(29.0%)2.498 (1.654–3.773)< 0.001OR: Odds ratio CI: Confidence interval LL: Lower limit UL: Upper Limit Comparison between the two studied groups according to the different genetic models for TGF-β1 C-509T OR: Odds ratio CI: Confidence interval LL: Lower limit UL: Upper Limit The analysis of the influence of TGF-β1 − 509 C/T polymorphisms on the demographic characteristics of TB patients revealed no statistically significant association with age, gender, or ethnic background in this cohort. The genotype distribution across the different age groups shows a balanced proportion of TT and TC genotypes, with no occurrence of the CC genotype in any group (p-value = 0.825). The genotype distribution of TT and TC among males was 51.0% and 49%, respectively. Among females, TT was 44.9% and TC was 55.1% (p-value = 0.458), indicating no association between the genotypes of TGF-β1 − 509 C/T and gender (Table 5). Table 5Influence of TGF-β1 −509 C/T polymorphisms on demographic characteristics of TB patientsPolymorphismCategory N Genotype p TGF.β1.C-509TAge group18–3096TT = 48(50.0%)0.825TC = 48(50.0)CC = 0(0.0%)31–4048TT = 22(45.8%)TC = 26(54.2%)CC = 0(0.0%)> 4056TT = 29(51.8%)TC = 27(48.2%)CC = 0(0.0%)GenderMale151TT = 77(51.0%)0.458TC = 74(49.0%)CC = 0(0.0%)Female49TT = 22(44.9%)TC = 27(55.1%)CC = 0(0.0%)Ethnic subgroupAfrican110TT = 54(49.1%)0.818TC = 56(50.9%)CC = 0(0.0%)Arab78TT = 40(51.3%)TC = 38(48.7%)CC = 0(0.0%)Nuba12TT = 5(41.7%)TC = 7(58.3%)CC = 0(0.0%) Table 5Influence of TGF-β1 −509 C/T polymorphisms on demographic characteristics of TB patientsPolymorphismCategory N Genotype p TGF.β1.C-509TAge group18–3096TT = 48(50.0%)0.825TC = 48(50.0)CC = 0(0.0%)31–4048TT = 22(45.8%)TC = 26(54.2%)CC = 0(0.0%)> 4056TT = 29(51.8%)TC = 27(48.2%)CC = 0(0.0%)GenderMale151TT = 77(51.0%)0.458TC = 74(49.0%)CC = 0(0.0%)Female49TT = 22(44.9%)TC = 27(55.1%)CC = 0(0.0%)Ethnic subgroupAfrican110TT = 54(49.1%)0.818TC = 56(50.9%)CC = 0(0.0%)Arab78TT = 40(51.3%)TC = 38(48.7%)CC = 0(0.0%)Nuba12TT = 5(41.7%)TC = 7(58.3%)CC = 0(0.0%) Influence of TGF-β1 −509 C/T polymorphisms on demographic characteristics of TB patients Regarding ethnicity, there was no statistically significant association between the genotype distribution and ethnic groups, with a p-value of 0.818. Although Nubas showed a slightly higher proportion of the TC genotype (58.3%), the small sample size limits the statistical power (Table 5). Logistic regression analysis The multivariate logistic regression analysis included all factors that showed a statistically significant association with tuberculosis (TB). The results ultimately indicated that five variables were significantly independently and directly linked with tuberculosis (TB) (Table 6). Table 6Univariate and multivariate logistic regression analysis for the parameters affecting the case group (n = 200 vs. 200)ParameterUnivariateMultivariate p OR (LL – UL 95%C.I) p OR (LL – UL 95%C.I) Age Less than 21 years®1.021–30 years0.5271.30 (0.577–2.930)31–40 years0.0900.494 (0.219–1.115)41–50 years0.0950.467 (0.191–1.142)51–60 years0.8741.083 (0.402–2.921)More than 61 years0.0903.521 (0.823–15.057) Male < 0.0013.272 (2.139–5.006)0.0012.820 (1.562–5.092) Ethnic group African< 0.0012.126 (1.424–3.174)0.9030.928 (0.279–3.085)Arab< 0.0010.435 (0.292–0.650)0.1360.403 (0.122–1.333)Nuba0.3621.532 (0.612–3.832) Rural 0.0431.512 (1.013–2.256)0.3581.260 (0.770–2.063) Occupation Employee0.0012.007 (1.336–3.017)0.2451.389 (0.799–2.414)Freelancer0.1941.406 (0.841–2.351)Housewife0.0130.484 (0.273–0.858)0.9151.045 (0.462–2.365)Student0.6810.893 (0.521–1.530)Unemployed0.0010.312 (0.156–0.622)0.0040.270 (0.110–0.662)TGF- β1 C-509T (TC + CC)< 0.0012.498 (1.654–3.773)< 0.0012.688 (1.638–4.411)OR Odds Ratio, CI = Confidence Interval, P P-value, LL Lower Limit of the 95% Confidence Interval, UL Upper Limit of the 95% Confidence Interval Table 6Univariate and multivariate logistic regression analysis for the parameters affecting the case group (n = 200 vs. 200)ParameterUnivariateMultivariate p OR (LL – UL 95%C.I) p OR (LL – UL 95%C.I) Age Less than 21 years®1.021–30 years0.5271.30 (0.577–2.930)31–40 years0.0900.494 (0.219–1.115)41–50 years0.0950.467 (0.191–1.142)51–60 years0.8741.083 (0.402–2.921)More than 61 years0.0903.521 (0.823–15.057) Male < 0.0013.272 (2.139–5.006)0.0012.820 (1.562–5.092) Ethnic group African< 0.0012.126 (1.424–3.174)0.9030.928 (0.279–3.085)Arab< 0.0010.435 (0.292–0.650)0.1360.403 (0.122–1.333)Nuba0.3621.532 (0.612–3.832) Rural 0.0431.512 (1.013–2.256)0.3581.260 (0.770–2.063) Occupation Employee0.0012.007 (1.336–3.017)0.2451.389 (0.799–2.414)Freelancer0.1941.406 (0.841–2.351)Housewife0.0130.484 (0.273–0.858)0.9151.045 (0.462–2.365)Student0.6810.893 (0.521–1.530)Unemployed0.0010.312 (0.156–0.622)0.0040.270 (0.110–0.662)TGF- β1 C-509T (TC + CC)< 0.0012.498 (1.654–3.773)< 0.0012.688 (1.638–4.411)OR Odds Ratio, CI = Confidence Interval, P P-value, LL Lower Limit of the 95% Confidence Interval, UL Upper Limit of the 95% Confidence Interval Univariate and multivariate logistic regression analysis for the parameters affecting the case group (n = 200 vs. 200) OR Odds Ratio, CI = Confidence Interval, P P-value, LL Lower Limit of the 95% Confidence Interval, UL Upper Limit of the 95% Confidence Interval Discussion The most important factor in determining susceptibility and/or resistance to many infectious diseases, including tuberculosis, remains host genetics. Consequently, several possible genetic variations were linked to the risk of tuberculosis. There is increasing interest in determining the genetic determinants influencing tuberculosis (TB) because it is known that genotypic differences in many cytokines are associated with higher susceptibility to TB infection [32, 33]. Furthermore, the genes encoding the regulatory and Th1 signature mediators may be crucial for the host’s vulnerability to tuberculosis, as the interactions between these mediators can affect a person’s immunological status. Studies on the connection between cytokine gene polymorphism and TB susceptibility carried out on different ethnic groups produced a range of findings [34–38]. Understanding the genetic polymorphism of the cytokines of interest in TB patients whose genetic profiles differ from those of Europeans and Asians is crucial in the era of tailored treatment. This study examines the possible correlation between Sudanese patients’ TB infection and polymorphisms in the TGF-β1 C-509T and TGF-β1 T869C genes. Such a relationship may account for the host genetic characteristics linked to other socioeconomic factors that enhance the risk of developing clinical tuberculosis in various ethnic groups. This study included 400 individuals, comprising 200 cases and 200 controls. Among the diagnosed cases, 49 (24.5%) were female and 111 (75.5%) were male (Table 7). The gender differences between the study groups were statistically significant (P-value < 0.001). According to the logistic regression analysis, Males faced nearly three times the risk compared to females (P-value = 0.001), OR = 2.820, 95% CI (1.562–5.092). Prior studies have confirmed the association between tuberculosis and gender [39–42]. Males were more TB-affected than females in both investigations. Furthermore, a significant percentage of the cases diagnosed in our study fell within the age range of 21 to 30 (Table 7). Similar results have been reported in previous studies [36, 43–47]. The high socioeconomic exposure of this age group or the high rate of HIV infection, which was not investigated in this study, could be the cause of this. Another statistically significant variation in the residence locations of the study groups had been revealed (P-value = 0.042), with 53.5% of the cases residing in rural areas and 46.5% in urban areas. Previous studies have reported similar findings in Sudan [47] and other geographical areas [43, 48]. Additionally, the results of this study revealed a statistically significant difference in the distribution of educational levels between cases and controls (P-value < 0.001) (Table 7). Nik Nor R et al. [41] and Elduma AH et al. [49] reported comparable outcomes. However, other studies revealed conflicting findings [50]. The occupation-related variation between the study groups was shown to differ significantly (P-value = 0.001). 48.0% of the cases were employed, 6% were unemployed, and 12.5% were housewives (Table 7). This outcome aligns with findings from earlier research [51, 52]. According to the logistic regression analysis, the risk of tuberculosis was reduced for unemployed individuals (OR = 0.270, 95% CI 0.110–0.662, P-value = 0.004) (Table 6). Due to their unemployment status and the airborne nature of tuberculosis, individuals may be less prone to overcrowding and social interaction [53, 54]. The current study revealed that Africans and Arabs were much more susceptible to TB than Nuba, according to the study’s logistic regression analysis, with P-values < 0.001 and percentages of 55%, 39%, and 6% for each race, respectively (Table 7). Milano M et al. reported a similar outcome [39]. For white individuals, the reported percentage was 71%, while for non-white individuals, it was 29%. Furthermore, TB prevalence varied among Sudan’s ethnic groupings, according to Sharaf Eldin GS et al. [47]. The distribution of tuberculosis varied significantly across different ethnic groups, with 47% of African Americans, 37% of Asians, 13% of Hispanics, and 3% of Caucasians represented, according to Condos R et al. [55]. Table 7Distribution of the cases and the control groups according to demographic dataCases (n = 200)Controls (n = 200)P-valueNO.%NO.%Less than 21 years168%136.5%0.56321–30 years8140%5025%0.00131–40 years4724%7939.5%0.00141–50 years2311.5%4020%0.02051–60 years2010%157.5%0.376More than 61 years136.5%31.5%0.011GenderMaleFemale15175.59748.5< 0.0014924.510351.5Ethnic groupAfrican11055.07336.5< 0.001Arab7839.011959.5Nuba126.084.0OccupationEmployee9648.06331.50.001Freelancer4120.53115.50.193Housewife2110.53919.50.012Student3015.03316.50.681Unemployed126.03417.00.001Marital StatusMarried10552.510653.00.920Single9045.08844.00.841Divorced42.052.51.000Widow10.510.51.00Educational LevelIlliterate4120.584.0< 0.001Khalwa2110.552.5Primary School5326.52412.0Secondary School3316.54623.0University5226.011758.5ResidenceRural10753.512763.50.042Urban9346.57336.5Onset (months)Min. – Max.0.50–14.0––Mean ± SD.4.54 ± 3.28––Median(IQR)3.0 (3.0–6.0)––Min Minimum, Max Maximum, SD Standard Deviation Table 7Distribution of the cases and the control groups according to demographic dataCases (n = 200)Controls (n = 200)P-valueNO.%NO.%Less than 21 years168%136.5%0.56321–30 years8140%5025%0.00131–40 years4724%7939.5%0.00141–50 years2311.5%4020%0.02051–60 years2010%157.5%0.376More than 61 years136.5%31.5%0.011GenderMaleFemale15175.59748.5< 0.0014924.510351.5Ethnic groupAfrican11055.07336.5< 0.001Arab7839.011959.5Nuba126.084.0OccupationEmployee9648.06331.50.001Freelancer4120.53115.50.193Housewife2110.53919.50.012Student3015.03316.50.681Unemployed126.03417.00.001Marital StatusMarried10552.510653.00.920Single9045.08844.00.841Divorced42.052.51.000Widow10.510.51.00Educational LevelIlliterate4120.584.0< 0.001Khalwa2110.552.5Primary School5326.52412.0Secondary School3316.54623.0University5226.011758.5ResidenceRural10753.512763.50.042Urban9346.57336.5Onset (months)Min. – Max.0.50–14.0––Mean ± SD.4.54 ± 3.28––Median(IQR)3.0 (3.0–6.0)––Min Minimum, Max Maximum, SD Standard Deviation Distribution of the cases and the control groups according to demographic data Male Female Min Minimum, Max Maximum, SD Standard Deviation In contrast, the present investigation did not reveal any statistically significant variation in the distribution of marital status among the different study groups (P-value >0.05) (Table 7). Previous studies reported the same outcome [47, 56]. Shariff NM et al. reached opposing conclusions in Kuala Lumpur [57] and Kota Bharu, Kelantan [41], Malaysia. The TGF-β1 gene is located on the long arm of chromosome 19, a potent macrophage-deactivating molecule that reduces the effectiveness of macrophages to contain Mycobacterium tuberculosis [58]. The − 509 C/T polymorphism is located in the promoter region of the TGF-β1 gene, affecting transcriptional activity and cytokine production. Previous functional studies have shown that the − 509 C allele is associated with increased promoter activity and increased TGF-β1 production, whereas the − 509T variant is associated with a relative decrease in transcription and cytokine secretion [19]. Elevated TGF-β1 levels (as might be promoted by the − 509 C allele) have been shown to suppress IFN-γ production and dampen Th1 responses, deactivate macrophage antimicrobial activity, and contribute to higher Mycobacterium tuberculosis replication in granulomatous lesions. Conversely, lower promoter activity (as seen with the − 509T allele) may limit these suppressive effects, allowing for more effective Th1 immunity, macrophage activation, and containment of the infection [59, 60]. A T/C substitution at position + 869 (codon 10) in exon 1 of the gene has been associated with high serum levels of TGF-β1 [61, 62]. There is evidence that the T869C TGF-β1 polymorphisms affect how susceptible people are to different diseases [63]. Previous studies showed that the TGF-β1 gene polymorphism at − 509 C/T (rs1800469) and + 869T/C (rs1800470) is correlated with the progression of chronic infectious diseases [64] and chronic immune-related lung diseases [65, 66]. The results of our study revealed a statistically significant association between the TGF-β1 − 509 C/T (rs1800469) polymorphism and tuberculosis in the Sudanese population (P-value < 0.001). TT genotype frequencies for patients and controls were 49.5% and 71%, respectively. Whereas the frequencies of the TC genotype were 50.5% and 29% for cases and controls, respectively. The TC genotype was significantly associated with TB and had a two-fold risk of the disease compared to the TT genotype (P-value < 0.001), OR = 2.498, 95% CI (1.654–3.773). The T allele was shown to confer protection against TB, while the C allele was found to increase the risk of the disease by almost two-fold (P-value < 0.001); the odds ratio (OR) was 1.992, with a confidence interval of 1.392–2.85 (Table 3). The findings of this study align with previous results obtained from Iran [67] and China [12]. Zhang S et al. investigated 10 SNPs in the TGF-β1 gene; 5 SNPs showed a statistically significant association with tuberculosis [12]. Analysis of the different genetic models of the TGF-β1 − 509 C/T polymorphism revealed that the C allele is significantly associated with increased susceptibility to tuberculosis in this study population. The effect appears to be driven by the heterozygous TC genotype, which confers approximately 2.5 times the risk of TB compared to the TT genotype (OR = 2.498, CI 1.654–3.773, and P-value < 0.001) (Table 4). Moreover, the analysis of the effect of the TGF-β1-509 C/T polymorphism on patients’ demographic variables showed that the genotype distribution did not differ significantly by age, gender, or ethnic subgroup. The absence of the homozygous CC genotype across all strata is consistent with the low frequency of the C allele in our study population, limited population admixture, and the high prevalence of consanguinity in the region, which together account for the deviation from Hardy-Weinberg equilibrium (Table 5). These factors can reduce allelic diversity and increase the likelihood of genotype clustering. Moreover, deviation from HWE in case–control studies can also arise from disease association, sample size constraints, or selection bias. Importantly, these findings suggest that while the C allele/TC genotype is associated with increased overall susceptibility to tuberculosis, its effect appears independent of demographic characteristics, indicating a general rather than subgroup-specific genetic influence on disease risk. Regarding the TGF-β1 + 869T/C (rs1800470) polymorphism, this study found no association between this SNP and tuberculosis in Sudanese patients. There was no statistically significant difference in genotype distribution between the two study groups; both cases and controls carried the TT genotype. The findings of this study align with the results reported in Japan [68], Colombia [69], Hong Kong, China [21], and Iran [67]. These conflicting results could be attributed to ethnic differences among groups and to the lack of an appropriate functional SNP selection technique. Limitations The study was conducted on a relatively small cohort, which may have limited the statistical power to detect subtle genetic effects or rare-allele associations. Moreover, in our study population, we did not detect the homozygous genotype CC for TGF-β1 T869C or TGF-β1 C-509T. This may reflect population-specific allele frequencies and genetic background, which could have influenced our findings. The absence of this allele in our sample restricts the ability to assess its potential role in TB susceptibility. Furthermore, we did not measure circulating levels of TGF-β1 or other cytokines in parallel with genotyping. Consequently, we cannot directly correlate the observed genotype distribution with functional protein expression or immune response. Including cytokine quantification would have strengthened the mechanistic interpretation of our genetic findings. In addition, the logistical challenges and financial constraints hinder the widespread implementation of IGRA or TST among study participants to rule out LTB in healthy controls. Recommendations Based on the study’s findings, there was a statistically significant difference between the patients and controls in the genotype and allele frequencies of the TGF-β1 − 509 C/T gene polymorphism. Future research, including studies with larger and ethnically diverse cohorts, is needed to validate these associations. Functional studies, including cytokine level measurement, would help clarify the mechanistic role of TGF-β1 variants in tuberculosis pathogenesis. carrying out more studies on treatment responsiveness and cytokine gene polymorphism is recommended. Suggest expanding to other TGF-β1 SNPs or other immune regulatory genes relevant to TB. Conclusion The results of the current study revealed a statistically significant association between the TGF-β1 509 C/T gene polymorphism and TB, with the C allele and the TC genotype conferring increased risk of TB in the Sudanese population. Furthermore, a statistically significant association between age, gender, ethnic group, occupation, and residence and the development of TB was reported. There were no statistically significant differences in the genotype and allele frequencies of the TGF-β1 T869C gene between the patients and controls. We recommend that future studies incorporate a larger sample size and diverse populations, complemented by mechanistic investigations to validate and expand upon our findings. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1